Kiromic BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1.14	3.2	0.65	25.35	10.15
Cash & Short-Term Investments	1.14	3.2	0.65	25.35	10.15
Cash Growth	-64.51%	396.59%	-97.45%	149.78%	426.18%
Other Receivables	-	-	-	0.02	-
Receivables	-	-	-	0.02	-
Prepaid Expenses	1.51	1.23	1.04	1.7	0.59
Restricted Cash	0.66	-	-	-	-
Total Current Assets	3.3	4.43	1.69	27.07	10.74
Property, Plant & Equipment	5.22	7.72	10.25	3.63	2.07
Other Long-Term Assets	0.02	0.02	0.02	0.03	0.02
Total Assets	8.55	12.17	11.97	30.73	12.83
Accounts Payable	2.68	2.14	7.31	2.21	0.67
Accrued Expenses	3.89	3.16	1.02	0.74	0.33
Short-Term Debt	13.66	14	4.37	0.45	0.47
Current Portion of Leases	0.69	0.63	0.58	-	-
Other Current Liabilities	-	0.45	-	-	-
Total Current Liabilities	20.9	20.38	13.28	3.41	1.47
Long-Term Debt	-	-	2.91	-	-
Long-Term Leases	0.23	0.91	1.54	-	-
Total Liabilities	21.13	21.29	17.74	3.41	1.47
Common Stock	0	0	0	0	0
Additional Paid-In Capital	137.21	113.78	96.17	94.54	52.99
Retained Earnings	-149.8	-122.9	-101.95	-67.22	-41.63
Total Common Equity	-12.59	-9.12	-5.77	27.32	11.36
Shareholders' Equity	-12.59	-9.12	-5.77	27.32	11.36
Total Liabilities & Equity	8.55	12.17	11.97	30.73	12.83
Total Debt	14.57	15.54	9.41	0.45	0.47
Net Cash (Debt)	-13.43	-12.34	-8.77	24.9	9.68
Net Cash Growth	-	-	-	157.16%	401.92%
Net Cash Per Share	-9.19	-11.24	-16.10	65.43	64.47
Filing Date Shares Outstanding	1.53	1.29	0.98	0.52	0.24
Total Common Shares Outstanding	1.53	1.26	0.65	0.52	0.24
Working Capital	-17.6	-15.95	-11.59	23.66	9.27
Book Value Per Share	-8.21	-7.25	-8.91	52.92	46.48
Tangible Book Value	-12.59	-9.12	-5.77	27.32	11.36
Tangible Book Value Per Share	-8.21	-7.25	-8.91	52.92	46.48
Machinery	3.47	3.26	3.18	1.61	0.8
Construction In Progress	0.02	0.1	-	1.23	0.45
Leasehold Improvements	7.37	7.37	7.3	1.46	1.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.